Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775259 | PMC |
| http://dx.doi.org/10.1016/j.pediatrneurol.2020.12.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Miller-Fisher/Guillain-Barré overlap syndrome following COVID-19 vaccination].
Rev Med Inst Mex Seguro Soc
May 2024
Instituto Mexicano del Seguro Social, Hospital General de Zona No. 1, Servicio de Neurología. Tepic, Nayarit, México.
Background: Anti-GQ1B syndrome includes a group of diseases characterized by antibody-mediated polyneuropathy. Guillain Barre syndrome (GBS) and the Miller-Fisher syndrome (MFS) have been related to COVID-19 vaccine application.
Clinic Case: 48-year-old man, with history of Pfizer-BioNTech vaccination against COVID-19, 5 days prior to the symptoms, who assisted to the Emergency room with blurred vision and diplopia; adding dysarthria, facial diplegia and left upper limb weakness after 48 hours.
Botulinum toxin-A in acute acquired comitant esotropia during COVID pandemic in children and young adolescents.
Indian J Ophthalmol
February 2025
Department of Paediatric Ophthalmology and Squint Services, Aravind Eye Hospital and Post Graduate Institute of Ophthalmology, Tirunelveli, Tamil Nadu, India.
Article Synopsis
- The study investigates the use of botulinum toxin A (BTX-A) in treating acute acquired comitant esotropia (AACE) in children and young adults, particularly related to increased screen time during the COVID-19 pandemic.
- Researchers analyzed data from 27 patients who received BTX-A injections to correct misalignment of the eyes caused by excessive use of devices like laptops and smartphones, focusing on the changes in eye deviation and binocular vision post-treatment.
- Results indicated that BTX-A was effective, with significant improvements in eye alignment and visual function noted, especially when treatment was administered early after symptom onset.
Internuclear Ophthalmoplegia Following COVID-19 with Abnormal Findings on Neuroimaging; A Case Report.
J Binocul Vis Ocul Motil
September 2024
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
COVID-19 had been reported to be associated with neuro-ophthalmic complications. However, there is a shortage of evidence regarding internuclear ophthalmoplegia (INO) presentation after COVID-19 infection with related brain magnetic resonance imaging (MRI). Herein, we report a case of INO in a 69-year-old woman with presentation of diplopia following COVID-19 infection, along with her neuroimaging.
View Article and Find Full Text PDFObjective: This article reviews the clinical and antibody spectrum of autoimmune cerebellar ataxia and other autoimmune movement disorders. It highlights characteristic phenotypes and red flags to the diagnosis and how these rare, but treatable, disorders are integrated into a differential diagnosis.
Latest Developments: An increasing number of neuronal antibodies have been identified in patients with cerebellar ataxia, for example, against Kelch-like protein 11 (KLHL11), seizure-related 6 homolog-like 2, septin-3 and septin-5, or tripartite motif containing protein 9 (TRIM9), TRIM46, and TRIM67.
Background: Corrective squint surgery has a significant psychological impact, affecting both the quality of life and mental health of patients. This study highlights the quantitative and subjective assessment of both the psychological and functional outcomes of squint surgery in adults having horizontal strabismus with no preoperative diplopia using a Quality-Of-Life Adult Strabismus 20 (QOL AS-20) questionnaire.
Method: The study is a retrospective cohort study on patients with uncomplicated, horizontal squint; with no vertical deviation and was conducted as part of a departmental clinical audit.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!